Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)

Pulmonx (LUNG) has disclosed Non-Current Deferred Tax Liability for 7 consecutive years, with $47000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 63.57% to $47000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $47000.0, a 63.57% decrease, with the full-year FY2024 number at $87000.0, down 23.68% from a year prior.
  • Non-Current Deferred Tax Liability was $47000.0 for Q3 2025 at Pulmonx, up from $41000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $140000.0 in Q1 2024 to a low of $37000.0 in Q4 2021.
  • A 5-year average of $79526.3 and a median of $71000.0 in 2021 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: soared 154.05% in 2022, then plummeted 65.25% in 2025.
  • Pulmonx's Non-Current Deferred Tax Liability stood at $37000.0 in 2021, then surged by 154.05% to $94000.0 in 2022, then grew by 21.28% to $114000.0 in 2023, then dropped by 23.68% to $87000.0 in 2024, then tumbled by 45.98% to $47000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non-Current Deferred Tax Liability are $47000.0 (Q3 2025), $41000.0 (Q2 2025), and $79000.0 (Q1 2025).